Medical
CSU researchers explore link between serotonin and mitral-valve disease
July 24th 2009Fort Collins, Colo. -- Veterinary researchers at Colorado State University discovered that cells in diseased heart valves of dogs and humans produce serotonin, which they believe may be the driving force behind mitral-valve disease in both.
University of Missouri researchers lab-grown cartilage molded into joint replacements
July 1st 2009Columbia, Mo. - Researchers at the University of Missouri School of Veterinary Medicine are growing cartilage in a lab that can be molded into permanent joint replacements for dogs and eventually humans.
USDA grants conditional license to Intervet/Schering-Plough for new canine influenza vaccine
June 23rd 2009Roseland, N.J. -- Intervet/Schering-Plough Animal Health introduces the first vaccine against canine influenza virus (CIV). The vaccine was granted a conditional product license by the U.S. Department of Agriculture (USDA) on May 27.
Intervet/Schering-Plough launches new canine Lyme vaccine
June 16th 2009National Report -- Intervet/Schering-Plough Animal Health just introduced Nobivac Lyme -- a vaccine specifically designed to provide protection by targeting two key outer-surface proteins involved in the transmission of canine Lyme disease, the company says.
MU study shows promise for early detection of OA in dogs
June 15th 2009Columbia, Mo. -- In a study that could have applications in human medicine as well, researchers at the University of Missouri are studying potential biomarkers in dogs that could lead to early diagnosis of osteoarthritis, helping identify patients at higher risk for the disease.
FDA approves Pfizer's Palladia to treat mast-cell tumors in dogs
June 3rd 2009Rockville, Md. -- Pfizer's Palladia (Toceranib phosphate) received approval by the Food and Drug Administration (FDA). The drug is the first one developed specifically for the treatment of cancer in dogs, the FDA reported today.